The bone marrow assay was consistent with French-American-British (FAB) classification criteria for APL diagnosis, later confirmed by the presence of promyelocytic leukemia-retinoic acid receptor α (PML-RARα) fusion gene, concurrent with FLT3-ITD mutation. The gene discussed is RARA; the disease is acute promyelocytic leukemia.